Myelodysplastic syndromes spatial clusters in disease etiology and outcome

References

• Nybakken GE, Bagg A. The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes. J Mol Diagn 2014;16:145–158.
   PubMed Web of Science ®Google Scholar
• Kplola Y, Gbito E, Garcia-Manero G, et al. Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromes. Cancer Causes Control 2014;25:425–435.
   PubMed Web of Science ®Google Scholar
• Mutetwa B, Fryzek J, Du Y, et al. Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma 2011; 52:265–272.
   PubMed Web of Science ®Google Scholar
• Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 2008;112:45–52.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Schoonen WM, Kantarjian H, et al. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst 2008;100:1542–1551.
   PubMed Web of Science ®Google Scholar
• Breccia M, Finsinger P, Loglisci G, et al. Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience. Leuk Lymphoma 2012;53:2439–2443.
   PubMed Web of Science ®Google Scholar
• Dinmohamed AG, Visser O, van Norden Y, et al. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010. Eur J Cancer 2014;50:1004–1012.
   PubMed Web of Science ®Google Scholar
• Ma X, Does M, Raza A, et al. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007;109:1536–1542.
   PubMed Web of Science ®Google Scholar
• Mauritzson N, Johansson B, Rylander L, et al. The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex. Br J Haematol 2001;113:347–56.
   PubMed Web of Science ®Google Scholar
• Cogle CR, Iannacone MR, Yu D, et al. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment. Leuk Res 2014;38:71–75.
   PubMed Web of Science ®Google Scholar
• Glauser TA, Sagatys EM, Williamson JC, et al. Current pathology practices in and barriers to MDS diagnosis. Leuk Res 2013;37: 1656–1661.
   PubMed Web of Science ®Google Scholar
• McQuilten ZK, Wood EM, Polizzotto MN, et al. Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study. Cancer 2014;120:1686–1694.
   PubMed Web of Science ®Google Scholar
• Dinmohamed AG, van Norden Y, Visser O, et al. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands. Leuk Res 2015;39:177–182.
   PubMed Web of Science ®Google Scholar
• Ma X. Epidemiology of myelodysplastic syndromes. Am J Med 2012;125(7 Suppl.):S2–5.
   PubMed Web of Science ®Google Scholar
• Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 2003;27:95–120.
   PubMed Web of Science ®Google Scholar
• Irons RD, Kerzic PJ. Cytogenetics in benzene-associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum. Ann N Y Acad Sci. 2014;1310:84–88.
   PubMed Web of Science ®Google Scholar
• Nisse C, Haguenoer JM, Grandbastien B, et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 2001;112:927–935.
   PubMed Web of Science ®Google Scholar
• Schnatter AR, Glass DC, Tang G, et al. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst 2012;104:1724–1737.
   PubMed Web of Science ®Google Scholar
• Strom SS, Gu Y, Gruschkus SK, et al. Risk factors of myelodysplastic syndromes: a case-control study. Leukemia 2005;19:1912–1918.
   PubMed Web of Science ®Google Scholar
• West RR, Stafford DA, Farrow A, et al. Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk Res 1995;19:127–139.
   PubMed Web of Science ®Google Scholar
• Du Y, Fryzek J, Sekeres MA, et al. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 2010;34:1–5.
   PubMed Web of Science ®Google Scholar
• Ma X, Lim U, Park Y, et al. Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol 2009;169:1492–1499.
   PubMed Web of Science ®Google Scholar
• Tong HY, Hu C, Yin XF, et al. A meta-analysis of the relationship between cigarette smoking and incidence of myelodysplastic syndromes. Plos One 2013;8.
   Web of Science ®Google Scholar
• Ma X, Selvin S, Raza A, et al. Clustering in the incidence of myelodysplastic syndromes. Leuk Res 2007;31:1683–1686.
   PubMed Web of Science ®Google Scholar
• Ross ME, Wakefield J, Davis S, et al. Spatial clustering of myelodysplastic syndromes (MDS) in the Seattle-Puget Sound region of Washington State. Cancer Causes Control 2010;21:829–838.
   PubMed Web of Science ®Google Scholar
• US Census. American FactFinder. Available at: http://factfinder2censusgov/faces/nav/jsf/pages/indexxhtml [accessed 10 August 2014].
   Google Scholar
• US Census. 2000 US Census Gazetteer Files. Available at: https://wwwcensusgov/geo/maps-data/data/gazetteer2000html [accessed 6August 2014.
   Google Scholar
• Kulldorff M. A spatial scan statistic. Communicat Statist Theory Meth 1997;26:1481–1496.
   Web of Science ®Google Scholar
• Kulldorff M, Athas WF, Feuer EJ, et al. Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am J Public Health 1998;88:1377–1380.
   PubMed Web of Science ®Google Scholar
• DeChello LM, Sheehan TJ. The geographic distribution of melanoma incidence in Massachusetts, adjusted for covariates. Int J Health Geogr 2006;5:31.
   PubMedGoogle Scholar
• Heffernan R, Mostashari F, Das D, et al. Syndromic surveillance in public health practice, New York City. Emerg Infect Dis 2004;10: 858–864.
   PubMed Web of Science ®Google Scholar
• Nordsborg RB, Meliker JR, Ersboll AK, et al. Space-time clustering of non-Hodgkin lymphoma using residential histories in a Danish case-control study. Plos One 2013;8.
   Web of Science ®Google Scholar
• Wheeler DC. A comparison of spatial clustering and cluster detection techniques for childhood leukemia incidence in Ohio, 1996–2003. Int J Health Geogr 2007;6:13.
   PubMed Web of Science ®Google Scholar
• Kulldorff M, Heffernan R, Hartman J, et al. A space-time permutation scan statistic for disease outbreak detection. PLoS Med 2005;2:e59.
   PubMed Web of Science ®Google Scholar
• Kulldorff M, Tango T, Park PJ. Power comparisons for disease clustering tests. Computat Stat Data Analysis 2003;42:665–684.
   Web of Science ®Google Scholar
• Lawson AB, Simeon S, Kulldorff M, et al. Line and point cluster models for spatial health data. Computat Stat Data Analysis 2007;51:6027–6043.
   Web of Science ®Google Scholar
• Zhang Z, Assunção R, Kulldorff M. Spatial scan statistics adjusted for multiple clusters. J Probability Statist 2010;2010:1–11.
   Google Scholar
• R statistical software. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria: R Development Core Team; 2008. Available at: http://wwwR-projectorg.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). National Center for Health Statistics. Health Data Interactive. Available at: www.cdc.gov/nchs/hdi.htm. Smoking, ages 18+:US, 1999–2013 (Source: NHIS) [accessed 26 May 2015].
   Google Scholar